Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening
Products
Crown Bioscience, a JSR Life Sciences company, has announced that trailblazing service offering, OrganoidXplore™. This large-scale organoid screening platform promises robust, reproducible, and clinically relevant output at record speed, accelerating cancer treatment development.
For details, please see the announcement from JSR Life Sciences LLC on URL.